Increased Urinary Angiotensinogen Is Precedent to Increased Urinary Albumin in Patients With Type 1 Diabetes

Joss, 2002, Diabetic nephropathy: how effective is treatment in clinical practice?, QJM, 95, 41, 10.1093/qjmed/95.1.41 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 Perkins, 2003, Regression of microalbuminuria in type 1 diabetes, N Engl J Med, 348, 2285, 10.1056/NEJMoa021835 Dzau, 1994, Tissue angiotensin system in cardiovascular medicine. A paradigm shift?, Circulation, 89, 493, 10.1161/01.CIR.89.1.493 Navar, 2002, Regulation of intrarenal angiotensin II in hypertension, Hypertension, 39, 316, 10.1161/hy0202.103821 Leehey, 2000, Role of angiotensin II in diabetic nephropathy, Kidney Int, 58, S93, 10.1046/j.1523-1755.2000.07715.x Kobori, 2007, The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease, Pharmacol Rev, 59, 251, 10.1124/pr.59.3.3 Ingelfinger, 1986, Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla, J Clin Invest, 78, 1311, 10.1172/JCI112716 Singh, 2005, A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli, Am J Physiol Renal Physiol, 288, F1183, 10.1152/ajprenal.00159.2003 Suzaki, 2007, Intrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats, Int J Biol Sci, 3, 40, 10.7150/ijbs.3.40 Miyata, 2008, Sequential activation of the reactive oxygen species/angiotensinogen/renin-angiotensin system axis in renal injury of type 2 diabetic rats, Clin Exp Pharmacol Physiol, 35, 922, 10.1111/j.1440-1681.2008.04938.x Katsurada, 2007, Novel sandwich ELISA for human angiotensinogen, Am J Physiol Renal Physiol, 293, F956, 10.1152/ajprenal.00090.2007 Kobori, 2008, Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases, J Am Soc Hypertens, 2, 349, 10.1016/j.jash.2008.04.008 Kobori, 2009, Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients, Hypertension, 53, 344, 10.1161/HYPERTENSIONAHA.108.123802 Premaratne, 2008, Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes, Diabetes Care, 31, 971, 10.2337/dc07-1588 Ingelfinger, 1990, In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system, J Clin Invest, 85, 417, 10.1172/JCI114454 Darby, 1995, In situ hybridization and immunohistochemistry of renal angiotensinogen in neonatal and adult rat kidneys, Cell Tissue Res, 281, 197, 10.1007/BF00583388 Lantelme, 2002, Effects of dietary sodium and genetic background on angiotensinogen and renin in mouse, Hypertension, 39, 1007, 10.1161/01.HYP.0000016177.20565.A0 Rohrwasser, 1999, Elements of a paracrine tubular renin-angiotensin system along the entire nephron, Hypertension, 34, 1265, 10.1161/01.HYP.34.6.1265 Kobori, 2003, Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension, Hypertension, 41, 42, 10.1161/01.HYP.0000050102.90932.CF